{"id":53189,"date":"2023-01-23T17:02:44","date_gmt":"2023-01-23T16:02:44","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/post-traumatic-stress-disorder-treatment-global-market-report-2022-increasing-rd-by-key-players-bolsters-growth-researchandmarkets-com\/"},"modified":"2023-01-23T17:02:44","modified_gmt":"2023-01-23T16:02:44","slug":"post-traumatic-stress-disorder-treatment-global-market-report-2022-increasing-rd-by-key-players-bolsters-growth-researchandmarkets-com","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/post-traumatic-stress-disorder-treatment-global-market-report-2022-increasing-rd-by-key-players-bolsters-growth-researchandmarkets-com\/","title":{"rendered":"Post-traumatic Stress Disorder Treatment Global Market Report 2022: Increasing R&D by Key Players Bolsters Growth – ResearchAndMarkets.com"},"content":{"rendered":"
\n

DUBLIN–(BUSINESS WIRE)–The “Post-traumatic Stress Disorder Treatment Market, by Drug Class, by Route of Administration, by Age Group, by Distribution Channel and by Region – Size, Share, Outlook, and Opportunity Analysis, 2022 – 2030”<\/a> report has been added to ResearchAndMarkets.com’s<\/strong> offering.\n<\/p>\n

<\/a><\/p>\n

\nPost-traumatic stress disorder (PTSD) is a psychiatric condition that may occur in people who have witnessed a traumatic shock like natural disaster, a life threatening event, car accident, sexual abuse etc. Symptoms of PTSD may generate after three months or even after a year. Most of the patients suffering from PTSD show symptoms like intrusive memories, avoidance, negative changes in thinking and changes in emotional and physical reactions.\n<\/p>\n

\nFor instance, sudden death of a loved one may cause PTSD in some people. People with PTSD have heightened sense of danger. According to the U.S. National centre for PTSD, it is estimated that about 15% of the veterans of Vietnam War and 12% of gulf war veterans have PTSD. According to American Psychiatric Association, women are twice likely to get PTSD as compared to men. Commonly prescribed drugs for post trauma stress disorder includes antidepressants, sertraline, fluoxetine, paroxetine, and others.\n<\/p>\n

\nMarket Dynamics<\/strong>\n<\/p>\n

\nIncreasing research and development activities by the key market players for the treatment of post-traumatic stress disorder is expected to boost the growth of the global post-traumatic stress disorder treatment market over the forecast period. For instance, in December 2021, Jazz Pharmaceuticals plc. a pharmaceutical company, announced that the company had enrolled its first patient in Phase 2 clinical trial evaluating the safety and efficacy of JZP150, an investigational first-in-class small molecule for the treatment of adults with post-traumatic stress disorder (PTSD). JZP150 is a highly selective inhibitor of the enzyme Fatty Acid Amide Hydrolase (FAAH), designed to address the underlying cause of PTSD (impairment of fear extinction and its consolidation), as well as patient’s associated symptoms such as anxiety, insomnia, and nightmares.\n<\/p>\n

\nKey Features of the Study:<\/strong>\n<\/p>\n